|
AU1016600A
|
|
Recombinant DNA
|
|
US6221657B1
|
|
Modified human C3 DNA sequences and vectors
|
|
GB9718816D0
|
|
Extracorporeal system
|
|
AU1933897A
|
|
Surfaces which prevent or reduce complement activation
|
|
AU2225797A
|
|
Down-regulation resistant C3 convertase
|
|
FI964848A
|
|
Modified biological material
|
|
GB9624028D0
|
|
Modified proteins
|
|
GB9622694D0
|
|
Surfaces
|
|
GB9614293D0
|
|
Modified proteins
|
|
GB9611896D0
|
|
Modified proteins
|
|
GB9606516D0
|
|
Surfaces
|
|
GB9606440D0
|
|
Extracorporeal systems
|
|
GB9606073D0
|
|
Surfaces
|
|
GB9605266D0
|
|
Irradiation
|
|
GB9604865D0
|
|
Modified proteins
|
|
NZ335046A
|
|
method of purifying or concentrating a DNA preparation involving spermine and spermidine
|
|
GB9520605D0
|
|
Irradiation
|
|
HUT77874A
|
|
Modified human c3 proteins
|
|
GB9517758D0
|
|
Compositions and their uses
|
|
GB9509102D0
|
|
Modified proteins
|
